|
Immunotherapy
Citations 191-200 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
- Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis-Mortari, Sarah A. McNearney, Gong H. Yun, Susan K. Fautsch, David McKenna, Chap Le, Todd E. Defor, Linda J. Burns, Paul J. Orchard, Bruce R. Blazar, John E. Wagner, Arne Slungaard, Daniel J. Weisdorf, Ian J. Okazaki, and Philip B. McGlave
Blood 2005; 105: 3051-3057.
[Abstract]
[Full text]
[PDF]
Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation
- Dinorah Friedmann-Morvinski, Alain Bendavid, Tova Waks, Daniel Schindler, and Zelig Eshhar
Blood 2005; 105: 3087-3093.
[Abstract]
[Full text]
[PDF]
Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA
- Daniela Dörfel, Silke Appel, Frank Grünebach, Markus M. Weck, Martin R. Müller, Annkristin Heine, and Peter Brossart
Blood 2005; 105: 3199-3205.
[Abstract]
[Full text]
[PDF]
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand
- Jens Dannull, Smita Nair, Zhen Su, David Boczkowski, Christian DeBeck, Benjamin Yang, Eli Gilboa, and Johannes Vieweg
Blood 2005; 105: 3206-3213.
[Abstract]
[Full text]
[PDF]
Eradication of B-CLL by autologous and allogeneic host nonreactive anti–third-party CTLs
- Fabian D. Arditti, Shraga Aviner, Benjamin Dekel, Rita Krauthgamer, Judith Gan, Arnon Nagler, Antonio Tabilio, Massimo Martelli, Alain Berrebi, and Yair Reisner
Blood 2005; 105: 3365-3371.
[Abstract]
[Full text]
[PDF]
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
- John R. Ohlfest, Joel L. Frandsen, Sabine Fritz, Paul D. Lobitz, Scott G. Perkinson, Karl J. Clark, Gary Nelsestuen, Nigel S. Key, R. Scott McIvor, Perry B. Hackett, and David A. Largaespada
Blood 2005; 105: 2691-2698.
[Abstract]
[Full text]
[PDF]
Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial
- Manfred Schmidt, Salima Hacein-Bey-Abina, Manuela Wissler, Frederique Carlier, Annick Lim, Claudia Prinz, Hanno Glimm, Isabelle Andre-Schmutz, Christophe Hue, Alexandrine Garrigue, Francoise Le Deist, Chantal Lagresle, Alain Fischer, Marina Cavazzana-Calvo, and Christof von Kalle
Blood 2005; 105: 2699-2706.
[Abstract]
[Full text]
[PDF]
Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy
- Deepa Trivedi, Roxanne Y. Williams, Richard J. O'Reilly, and Guenther Koehne
Blood 2005; 105: 2793-2801.
[Abstract]
[Full text]
[PDF]
Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating concept
- Heike Zeitler, Gudrun Ulrich-Merzenich, Lothar Hess, Eligius Konsek, Christoph Unkrig, Peter Walger, Hans Vetter, and Hans-Hermann Brackmann
Blood 2005; 105: 2287-2293.
[Abstract]
[Full text]
[PDF]
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells
- Aurore Saudemont, Nathalie Jouy, Dominique Hetuin, and Bruno Quesnel
Blood 2005; 105: 2428-2435.
[Abstract]
[Full text]
[PDF]
|
|
